Validity of HELT-E2S2 Score in Predicting Ischemic Stroke in Japanese Patients With Non-Valvular Atrial Fibrillation With Cardiac Implantable Electronic Devices
Circulation Journal · 2025
DOI: 10.1253/circj.cj-24-0715 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Circulation Journal, 2025. Verfasst von Miyo Nakano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke, Defibrillators, Implantable. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: The HELT-E2S2score, a novel risk stratification system, was developed to determine the incidence of ischemic stroke in Japanese patients with non-valvular atrial fibrillation (NVAF). It has been suggested that the HELT-E2S2score is more useful than the CHADS2and CHA2DS2-VASc scores for Japanese patients with NVAF. This study determined the incidence of ischemic stroke in patients with NVAF and cardiac implantable electronic devices (CIEDs) and assessed the validity of the HELT-E2S2score in this population. METHODS AND RESULTS: We retrospectively analyzed the database of the CIED clinic of Chiba University Hospital and investigated the incidence of ischemic stroke according to the HELT-E2S2score. Of the 730 consecutive patients who were followed-up at the CIED clinic, those without NVAF were excluded, leaving 362 patients in this study (mean [±SD] follow-up period, 64±48 months; mean age, 73±16 years; 65% male). The mean CHADS2and CHA2DS2-VASc scores were 1.8±1.2 and 2.8±1.6 points, respectively. During follow-up, 31 (8.6%) patients experienced ischemic stroke. The c-statistic for the HELT-E2S2score was 0.719 (95% confidence interval [CI] 0.657-0.795), which was higher than the c-statistics for the CHADS2(0.704; 95% CI 0.647-0.768; P=0.025) and CHA2DS2-VASc (0.700; 95% CI:0.621-0.747; P=0.0097) scores. CONCLUSIONS: Risk stratification for ischemic stroke using the HELT-E2S2score is valid in Japanese patients with NVAF and CIEDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine.
- Department of Biostatistics, Graduate School of Medicine, Saitama Medical University.
- Department of Advanced Cardiorhythm Therapeutics, Chiba University Graduate School of Medicine.
- Department of Advanced Arrhythmia Bioengineering, Chiba University Graduate School of Medicine.
Zitieren
APA
Nakano, M., Kondo, Y., Shiko, Y., Nakano, M., Kajiyama, T., Ito, R., Chiba, T., Yoshino, Y., Ryuzaki, S., Takanashi, Y., Komai, Y., Narumi, S., & Kobayashi, Y. (2025). Validity of HELT-E2S2 Score in Predicting Ischemic Stroke in Japanese Patients With Non-Valvular Atrial Fibrillation With Cardiac Implantable Electronic Devices. Circulation Journal. https://doi.org/10.1253/circj.cj-24-0715
Vancouver
Nakano M, Kondo Y, Shiko Y, Nakano M, Kajiyama T, Ito R, et al. Validity of HELT-E2S2 Score in Predicting Ischemic Stroke in Japanese Patients With Non-Valvular Atrial Fibrillation With Cardiac Implantable Electronic Devices. Circulation Journal. 2025. doi:10.1253/circj.cj-24-0715
BibTeX
@article{Nakano2025,
author = {Nakano, Miyo and Kondo, Yusuke and Shiko, Yuki and Nakano, Masahiro and Kajiyama, Takatsugu and Ito, Ryo and Chiba, Toshinori and Yoshino, Yutaka and Ryuzaki, Satoko and Takanashi, Yukiko and Komai, Yuya and Narumi, Shoko and Kobayashi, Yoshio},
title = {Validity of HELT-E2S2 Score in Predicting Ischemic Stroke in Japanese Patients With Non-Valvular Atrial Fibrillation With Cardiac Implantable Electronic Devices},
journal = {Circulation Journal},
year = {2025},
doi = {10.1253/circj.cj-24-0715}
}
EUVIMED